Javascript must be enabled to continue!
Comparison of early and late intravenous infusion of milrinone in children upto 1 year undergoing cardiac surgery.
View through CrossRef
Objective: To compare the effects of early and late use of milrinone in children upto 1 year undergoing complex cardiac surgery. Study design:- prospective randomized study. Methods:
A prospective study involved 30 children undergoing congenital corrective cardiac surgery,classified randomly into two groups. Group A: Milrinone infusion was started without loading dose at 0.5mcg/kg/min at the beginning of CPB and continued postoperatively (0.5-0.75 mcg/kg/min) in the paediatric cardiac surgical ICU . Group B: Milrinone was started as a loading dose of 50mcg/kg over 10 min after aortic declamping and continued as infusion postoperatively at 0.5-0.75 mcg/kg/min in the pediatric cardiac surgical ICU.Data were collected at baseline, 1st ,6th and 12th postoperative hours in the ICU. Results: The inotropic supports and mechanical supports were needed more in group B than group A. The comparison of heart rate, CVP were insignificant between the two groups (P>0.05). The mean arterial blood pressure through the first 6 hours postoperatively was higher in group A than group B (P<0.05), but became insignificant through other timepoints. The urine output and central venous oxygen saturation were higher in group A than group B (P<0.05).The serum lactate levels were significantly higher in group B more than group A (P<0.05). Conclusion:Early use of milrinone, lead to easy weaning from Cardiopulmonary bypass, decreased requirement of pharmacological and mechanical support and decreased incidence of low cardiac output syndrome after pediatric cardiac surgery and there was no complications related to milrinone in our study patients.
Dr. Vithalrao Vikhe Patil Foundation, Ahmednagar
Title: Comparison of early and late intravenous infusion of milrinone in children upto 1 year undergoing cardiac surgery.
Description:
Objective: To compare the effects of early and late use of milrinone in children upto 1 year undergoing complex cardiac surgery.
Study design:- prospective randomized study.
Methods:
A prospective study involved 30 children undergoing congenital corrective cardiac surgery,classified randomly into two groups.
Group A: Milrinone infusion was started without loading dose at 0.
5mcg/kg/min at the beginning of CPB and continued postoperatively (0.
5-0.
75 mcg/kg/min) in the paediatric cardiac surgical ICU .
Group B: Milrinone was started as a loading dose of 50mcg/kg over 10 min after aortic declamping and continued as infusion postoperatively at 0.
5-0.
75 mcg/kg/min in the pediatric cardiac surgical ICU.
Data were collected at baseline, 1st ,6th and 12th postoperative hours in the ICU.
Results: The inotropic supports and mechanical supports were needed more in group B than group A.
The comparison of heart rate, CVP were insignificant between the two groups (P>0.
05).
The mean arterial blood pressure through the first 6 hours postoperatively was higher in group A than group B (P<0.
05), but became insignificant through other timepoints.
The urine output and central venous oxygen saturation were higher in group A than group B (P<0.
05).
The serum lactate levels were significantly higher in group B more than group A (P<0.
05).
Conclusion:Early use of milrinone, lead to easy weaning from Cardiopulmonary bypass, decreased requirement of pharmacological and mechanical support and decreased incidence of low cardiac output syndrome after pediatric cardiac surgery and there was no complications related to milrinone in our study patients.
Related Results
Nimodipine vs. Milrinone – Equal or Complementary Use? A Retrospective Analysis
Nimodipine vs. Milrinone – Equal or Complementary Use? A Retrospective Analysis
BackgroundCerebral vasospasm (CVS) continues to account for high morbidity and mortality in patients surviving the initial aneurysmal subarachnoid hemorrhage (SAH). Nimodipine is t...
Milrinone is associated with lower in hospital mortality in patients with cardiogenic shock: a retrospective analysis of the MIMIC-III database
Milrinone is associated with lower in hospital mortality in patients with cardiogenic shock: a retrospective analysis of the MIMIC-III database
Abstract
BackgroundAlthough milrinone has been widely used in daily clinical practice, its effect on survival in patients with cardiogenic shock (CS) is not known. The prim...
Modern approaches to infusion therapy in pediatrics and chemotherapy
Modern approaches to infusion therapy in pediatrics and chemotherapy
Background. Systems for intravenous administration of blood products and drugs are divided into the systems for transfusion (pore diameter – 114-200 μm) and systems for infusion (p...
Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia
Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia
OBJECTIVEIntravenous (IV) milrinone is a promising option for the treatment of cerebral vasospasm with delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSA...
Nasal and Intravenous Administration of Dexmedetomidine to Prevent the Emergence Agitation After the Vascular Interventional Surgery in Children: A Randomized, Double-blind, Controlled Study
Nasal and Intravenous Administration of Dexmedetomidine to Prevent the Emergence Agitation After the Vascular Interventional Surgery in Children: A Randomized, Double-blind, Controlled Study
Abstract
Introduction: Dexmedetomidine reduces the incidences of postanesthetic restlessness and hemodynamic fluctuations in children within acceptable ranges. Dexmedetomid...
Intravenous Ribavirin Treatment for Severe Adenovirus Disease in Immunocompromised Children
Intravenous Ribavirin Treatment for Severe Adenovirus Disease in Immunocompromised Children
Background. Adenovirus is an important cause of morbidity and mortality in the immunocompromised host. The incidence of severe adenovirus disease in pediatrics is increasing in ass...
A review of the adverse effects of intravenous immunoglobulin infusion in pediatric multisystem inflammatory disease patients (MIS-C)
A review of the adverse effects of intravenous immunoglobulin infusion in pediatric multisystem inflammatory disease patients (MIS-C)
Abstract
Background
Multisystem inflammatory syndrome in children (MIS-C) are associated with systemic inflammation and intravenous immunoglobulin (IVIG) infusion is the f...
Efficacy of milrinone plus sildenafil in the treatment of neonates with persistent pulmonary hypertension: A single center, randomized controlled trial from a resource limited setting.
Efficacy of milrinone plus sildenafil in the treatment of neonates with persistent pulmonary hypertension: A single center, randomized controlled trial from a resource limited setting.
Objective: To compare the outcomes of milrinone plus sildenafil versus sildenafil alone in the treatment of persistent pulmonary hypertension (PPH) in neonates. Study Design: Rando...

